Monday, January 15, 2018 10:45:10 PM
https://www.sec.gov/fast-answers/answersreversesplithtm.html
I have read through Bio-path's bylaws tonight. The phrases "broker non-votes", "reverse stock split" and "stock split" do not occur in the document. There are of course references to voting and voting procedures by the shareholders. It says nothing about what constitutes a "routine" or "non-routine" proposal.
I have searched documents regarding Delaware General Corporate Law (DGCL) but have been unable to find any specific or helpful information about Delaware law regarding Reverse Stock Splits.
Since it appears to come down to state law and/or the bylaws, I will reach out to the Delaware law firm tomorrow to ask a few questions. I have prepared a document with links to relevant information that may make it easier for an attorney to research our questions. It can be easily emailed to them if it seems reasonable to proceed.
I would hope that if reverse stock splits are governed by Delaware General Corporate Law, a Delaware attorney practicing in that area would have a pretty quick answer about what the law states about how to handle "broker non-votes". It may come down to a legal opinion on the bylaws.
(I received another call from an OpGen representative today while I was out, looking to get my proxy votes for their shareholder meeting on Wednesday regarding their reverse stock split proposal in which they clearly state that broker non-votes will count "against" the proposal. They are also a company incorporated in Delaware and traded on the Nasdaq. I could not find their bylaws online to see if they specifically stipulate how to handle such a proposal, but they clearly state in their shareholder voting material that they consider a reverse stock split to be a non-routine proposal.)
BTW, In re-reading Doug Morris' response to Brettj (post #3450), are we to conclude that Bio-Path contacted ALL brokers of shareholders who did not personally respond or give directives AND received a vote "For" proposals 3 and 4? In Bio-Path's voting results they list no "Broker non-votes" for proposals 3 and 4, instead combining those numbers into the "For" column? Can someone help me with that?
See: http://www.biopathholdings.com/wp-content/uploads/2017/12/BPTH_8K_20171227.pdf
In Section 2.9 of the bylaws it sets forth guidelines for "Inspectors of Elections" who are to oversee the "validity and counting of proxies and ballots" (2.9 (d)). Maybe shareholders have the right to see any proxy votes that brokers entered - which I imagine should include a record of the name of a broker, which shareholder they were representing, how many shares were represented and the date they were contacted and entered that vote. If it gets that far, I'll ask the attorney to interpret that section of the bylaws for me.
See bylaws here: http://www.biopathholdings.com/wp-content/uploads/2016/04/Bylaws_of_Bio-Path_Holdings__Inc__DE.pdf
I'll let you know what I find out.
Recent BPTH News
- Bio-Path Holdings, Inc. Announces Closing of $1.2 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules • GlobeNewswire Inc. • 04/19/2024 04:14:04 PM
- Bio-Path Holdings, Inc. Announces $1.2 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules • GlobeNewswire Inc. • 04/18/2024 05:57:59 PM
- Bio-Path Holdings Announces Successful Completion of Higher Dose Second Cohort in Phase 1/1b Clinical Trial of BP1002 in Refractory/Relapsed Acute Myeloid Leukemia (AML) Patients • GlobeNewswire Inc. • 04/18/2024 11:00:00 AM
- Bio-Path Holdings Expands Global Patent Portfolio • GlobeNewswire Inc. • 04/15/2024 11:00:00 AM
- Bio-Path Holdings Provides 2024 Clinical and Operational Update • GlobeNewswire Inc. • 04/02/2024 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/11/2024 11:00:34 AM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 03/08/2024 10:11:50 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/08/2024 12:10:34 PM
- Bio-Path Holdings Reports Full Year 2023 Financial Results • GlobeNewswire Inc. • 03/08/2024 12:00:00 PM
- U.S. Index Futures Fluctuate Ahead of Key Jobs Report; Oil Prices Dip • IH Market News • 03/08/2024 11:22:25 AM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/07/2024 09:21:27 PM
- Bio-Path Holdings to Announce Fourth Quarter and Full Year 2023 Financial Results on March 8, 2024 • GlobeNewswire Inc. • 03/01/2024 12:00:00 PM
- Form RW - Registration Withdrawal Request • Edgar (US Regulatory) • 02/29/2024 11:00:30 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/23/2024 12:01:09 PM
- Bio-Path Holdings Announces 1-for-20 Reverse Stock Split • GlobeNewswire Inc. • 02/21/2024 12:00:00 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/02/2024 09:39:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/02/2024 09:10:23 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/23/2024 10:20:23 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 01/23/2024 09:51:03 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 01/17/2024 09:52:48 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/10/2024 09:10:09 PM
- Bio-Path Holdings Announces Completion of First Dose Cohort in Phase 1 Clinical Trial Evaluating BP1002 to Treat Refractory/Relapsed Lymphoma and Refractory/Relapsed Chronic Lymphocytic Leukemia Patients • GlobeNewswire Inc. • 01/10/2024 12:00:00 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 01/04/2024 10:18:53 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 12/22/2023 09:06:16 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 12/22/2023 09:05:51 PM
Bantec Reports an Over 50 Percent Increase in Sales and Profits in Q1 2024 from Q1 2023 • BANT • Apr 25, 2024 10:00 AM
Cannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA • BLO • Apr 25, 2024 8:52 AM
Kona Gold Beverages, Inc. Announces Name Change to NuVibe, Inc. and Initiation of Ticker Symbol Application Process • KGKG • Apr 25, 2024 8:30 AM
Axis Technologies Group and Carbonis Forge Ahead with New Digital Carbon Credit Technology • AXTG • Apr 24, 2024 3:00 AM
North Bay Resources Announces Successful Equipment Test at Bishop Gold Mill, Inyo County, California • NBRI • Apr 23, 2024 9:41 AM
Epazz, Inc.: CryObo, Inc. solar Bitcoin operations will issue tokens • EPAZ • Apr 23, 2024 9:20 AM